Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Japan
MedTech
Lantheus taps GE HealthCare to sell its PSMA PET tracer in Japan
Lantheus gave GE HealthCare the rights to its Pylarify prostate cancer imaging agent in Japan, which plans to lean on its Nihon Medi-Physics division.
Conor Hale
Sep 24, 2025 11:30am
Japan biotech inks RNA research pact that includes mRNA compounds
Sep 19, 2025 10:49am
Kissei pays Viridian $70M to challenge Amgen for Japanese market
Jul 30, 2025 4:50am
AN Venture Partners raises $200M to boost Japan biotech industry
Jul 2, 2025 11:45am
FDA moves to block Olympus endoscope imports
Jun 25, 2025 12:05pm
Astellas offers lab space to help Japanese biotechs 'go global'
Jun 13, 2025 4:41am
